Steven Perrin

Steven Perrin

Fortuna: 3 810 $ al 31/05/2026

61 años
Health Technology
Consumer Services
Commercial Services

Perfil

Steven N.
Perrin
is the founder of Anelixis Therapeutics, Inc., founded in 2013, where the titles held included President, CEO, Treasurer & Director.
Current jobs include Executive Chairman at ALS Therapy Development Foundation, Inc. since 2018 (job started in 2007) and President, Chief Scientific Officer & Director at Eledon Pharmaceuticals, Inc. since 2020.
Former jobs include Associate Director-Molecular Profiling at Biogen, Inc. from 2001 to 2006, Scientist at Biogen MA, Inc., ARIAD Pharmaceuticals, Inc., and Aventis Pharmaceuticals, Inc., Assistant Professor at Boston University, Principal at Hoechst Ariad Genomics Center Llc, and Associate Professor at Boston University School of Medicine.
Education includes an undergraduate degree from Boston College in 1987 and a doctorate from Boston University School of Medicine in 1994.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
31/03/2026 1.000 ( 0 % ) 3 810 $ 31/05/2026

Cargos activos de Steven Perrin

EmpresasCargoInicio
ELEDON PHARMACEUTICALS, INC. Presidente 14/09/2020
Presidente 01/06/2010

Antiguos cargos conocidos de Steven Perrin.

EmpresasCargoFin
BIOGEN INC. Corporate Officer/Principal 01/12/2006
Corporate Officer/Principal -
Fundador -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Steven Perrin.

Formación de Steven Perrin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

86

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology